Fairhaven Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-441
Closed -$229K 121
2024
Q3
$229K Hold
441
0.07% 104
2024
Q2
$239K Buy
441
+1
+0.2% +$529 0.08% 101
2024
Q1
$228K Sell
440
-2
-0.5% -$995 0.08% 108
2023
Q4
$208K Buy
+442
New +$204K 0.08% 102
2023
Q3
Sell
-586
Closed -$260K 122
2023
Q2
$260K Buy
+586
New +$270K 0.1% 92
2022
Q4
$309K Buy
602
+7
+1% +$3.55K 0.13% 75
2022
Q3
$270K Buy
595
+50
+9% +$23.9K 0.12% 77
2022
Q2
$263K Buy
545
+135
+33% +$66.8K 0.12% 82
2022
Q1
$201K Buy
+410
New +$187K 0.08% 113
2021
Q4
Sell
-563
Closed -$210K 124
2021
Q3
$210K Sell
563
-4
-0.7% -$1.52K 0.09% 103
2021
Q2
$216K Sell
567
-6
-1% -$2.29K 0.09% 105
2021
Q1
$206K Sell
573
-90
-14% -$28.9K 0.09% 103
2020
Q4
$213K Buy
+663
New +$203K 0.09% 101
2019
Q2
Sell
-1,114
Closed -$320K 80
2019
Q1
$320K Sell
1,114
-86
-7% -$24.9K 0.3% 46
2018
Q4
$315K Buy
+1,200
New +$330K 0.31% 46

Other funds holding ELV

Fairhaven Wealth Management's ELV Position: Q4 2024 in Review

Fairhaven Wealth Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 441 shares — an estimated $229K sold.

Fairhaven Wealth Management first reported a position in ELV in Q4 2018 and held it in 15 quarters. The position peaked at $320K in Q1 2019. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Fairhaven Wealth Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Fairhaven Wealth Management sold 441 Elevance Health shares in Q4 2024, an estimated $229K.
  • Fairhaven Wealth Management first reported a position in Elevance Health in Q4 2018 and held it in 15 quarters.
  • Fairhaven Wealth Management's Elevance Health position peaked at $320K in Q1 2019.
  • 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Fairhaven Wealth Management's 13F filing for Q4 2024, filed 4 Feb 2025.